Author(s): Radhakrishna B, Ashok M, Harish PL, Veera Jyothsna M, Shivalinge Gowda KP.

Email(s): shivalinge65@gmail.com

DOI: Not Available

Address: Radhakrishna B., Ashok M., Harish P.L., Veera Jyothsna M. and Shivalinge Gowda K.P.*
Department of Pharmacology, P.E.S. College of Pharmacy, Hanumanthanagara, Bangalore-560050
*Corresponding Author

Published In:   Volume - 3,      Issue - 6,     Year - 2011


ABSTRACT:
Osteoporosis represents a weakening of bone tissue due to an imbalance in the dynamic processes of bone formation and bone resorption that are continually ongoing within bone tissue. Most currently available osteoporosis therapies are antiresorptive agents. Promising new drugs are currently under investigation by the FDA for the treatment of osteoporosis. Majority of the drugs used in osteoporosis are antiresorptive agents. These drugs act by inhibiting osteoclastic bone resorption and thus slowing the loss of bone mass. However these drugs do not stimulate new drug formation and does not increase true bone mass. The only FDA approved bone anabolic agent is PTH. It is the most beneficial agent for the patients with very low bone mass. Clinical trials are undergoing for denosumab. One of the new drug strontium ranelate acts by stimulating the bone formation and inhibiting bone resorption. More recent research indicates that dietary sources of phytoestrogens may increase osteoprotegerin production and help prevent bone loss and bone resorption; however, rigorous data are needed before clinical recommendations can be made. This review discusses the use of currently available agents as well as highlighting emerging agents expected to bring significant changes to the approach to osteoporosis therapy in the near future.


Cite this article:
Radhakrishna B, Ashok M, Harish PL, Veera Jyothsna M, Shivalinge Gowda KP. Current and Future Trends of Drugs Used in Osteoporosis. Research J. Pharmacology and Pharmacodynamics. 2011; 3(6): 329-333.


Recomonded Articles:

Author(s): John Masih, Sanjay Kumar, Deepak Kumar

DOI: 10.5958/2321-5836.2018.00013.7         Access: Open Access Read More

Author(s): Bhagwan Gamaji Ambhore, Kavita Ambhore, Dilip N Dhekale.

DOI: Not Available         Access: Open Access Read More

Author(s): Bhagwan Gamaji Ambhore , Kavita Ambhore.

DOI: Not Available         Access: Open Access Read More

Author(s): Hina Kausar, Dhekale DN, Mohammed Ubaid-Ur- Rahaman.

DOI: Not Available         Access: Open Access Read More

Author(s): Singh KK, Patle DR, US Paikra.

DOI: 10.5958/2321-5836.2015.00031.2         Access: Open Access Read More

Author(s): Hina Kausar, HB Rathi ,Mohammed Ubaid Ur Rahaman.

DOI: Not Available         Access: Open Access Read More

Author(s): Thakur Amit K, Singh Khileswar , Masih John.

DOI: Not Available         Access: Open Access Read More

Author(s): Hina Kausar, Mohammed Ubaid-Ur-Rahaman.

DOI: Not Available         Access: Open Access Read More

Author(s): Radhakrishna B, Ashok M, Harish PL, Veera Jyothsna M, Shivalinge Gowda KP.

DOI: Not Available         Access: Open Access Read More

Author(s): Hina Kausar, Dhekale Dilip N, Mohammed Ubaid-Ur-Rahaman.

DOI: Not Available         Access: Open Access Read More

Author(s): John Masih, Bansal A, Thakur Amit K , Painkara US.

DOI: Not Available         Access: Open Access Read More

Author(s): John Masih,Bansal A, Thkur Amit K , Painkara US.

DOI: Not Available         Access: Open Access Read More

Author(s): Aathira Menon, Apthadevi, Roshni P R

DOI: 10.5958/2321-5836.2019.00021.1         Access: Closed Access Read More

Research Journal of Pharmacology and Pharmacodynamics (RJPPD) is an international, peer-reviewed journal....... Read more >>>

RNI: Not Available                     
DOI: 10.5958 2321-5836 


Recent Articles




Tags